Geode Capital Management, LLC Pet Vivo Holdings, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.99 - $1.46 $4,216 - $6,218	4,259 Added 7.02%	64,953 $69,000
Q3 2023 Nov 13, 2023	BUY	$1.72 - $2.45 $23,476 - $33,440	13,649 Added 29.01%	60,694 $111,000
Q4 2022 Feb 13, 2023	SELL	$1.85 - $2.69 $218 - $317	-118 Reduced 0.25%	47,045 $94,000
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.63 $7,855 - $15,893	6,043 Added 14.7%	47,163 $74,000
Q1 2022 May 13, 2022	BUY	$1.25 - $3.97 $11,772 - $37,389	9,418 Added 29.71%	41,120 $83,000
Q4 2021 Feb 11, 2022	SELL	$2.4 - $5.01 $62,721 - $130,931	-26,134 Reduced 45.19%	31,702 $119,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $9.25 $151,530 - $534,983	57,836 New	57,836 $157,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $5.04M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.